To evaluate differences at the genomic level, a study on glioma using transgenic mice models validated that glioma TAMs expressed Arg1 (an M2 marker) shortly after trafficking into tumors, the expression of which was stimulated relatively later by microglia (76), which may reveal different responses of TAMs with distinct origins to tumor growth. Here, ARG1 is linked to central nervous system cancer.